Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study

BACKGROUND: Palmitoylethanolamide (PEA) is emerging as a new therapeutic approach in pain and inflammatory conditions, and it has been evaluated in studies on various painful diseases. The aim of this open-label study was to evaluate the efficacy of ultramicronized PEA (umPEA) in the prophylactic tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Papetti, Laura, Sforza, Giorgia, Tullo, Giulia, Alaimo di Loro, Pierfrancesco, Moavero, Romina, Ursitti, Fabiana, Ferilli, Michela Ada Noris, Tarantino, Samuela, Vigevano, Federico, Valeriani, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196162/
https://www.ncbi.nlm.nih.gov/pubmed/32377286
http://dx.doi.org/10.1155/2020/3938640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196162/
https://www.ncbi.nlm.nih.gov/pubmed/32377286
http://dx.doi.org/10.1155/2020/3938640

Ejemplares similares